Approaching the end of the second decade of the21st century, Parasitic Diseases remain a threat to human and animal health. Chemotherapy, the most efficient strategy to treat and control these diseases, has important limitations and new drugs are urgently needed. By uniting renowned and young scientists from a wide diversity of backgrounds, COST Action 1307 creates the synergistic interactions that can change this scenario and lead to efficient anti-parasitic drug discovery.
Presenter: Ana Tomás, i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto and ICBAS, Instituto de Ciências Biomédicas Abel Salazar, Porto, Portugal. COST Action CM1307
Contact: Silvia Alexe, Communications Officer, COST